BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
271.41036
NSE Symbol
ALIVUS
Divident Yield %
0.36
Market Cap
(Rs In Cr.)
16,866
P/E (TTM)
27.13
EPS (TTM)
50.64
Face Value
(Rs)
2
Back
Alivus Life Sciences standalone net profit rises 31.71% in the June 2026 quarter
31-Jul-26   Hrs IST

Net profit of Alivus Life Sciences rose 31.71% to Rs 160.08 crore in the quarter ended June 2026 as against Rs 121.54 crore during the previous quarter ended June 2025. Sales rose 6.41% to Rs 640.41 crore in the quarter ended June 2026 as against Rs 601.85 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales640.41601.85 6
OPM %33.0628.63 -
PBDT232.81180.05 29
PBT212.22162.99 30
NP160.08121.54 32

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)